Strados Labs Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
48
- Latest Deal Type
-
2ndary - Private
- Investors
-
26
Strados Labs General Information
Description
Developer of medical-grade respiratory monitoring technology designed to provide continuous evidence for clinical trials. The company's platform features proprietary biosensing, artificial intelligence detection, expert overread, and ambulatory monitoring, enabling pharmaceutical sponsors to capture lung sounds, cough frequency, and spirometry data from patients in real-world settings for regulatory submissions.
Contact Information
Website
www.stradoslabs.comCorporate Office
- 1315 Walnut Street
- Suite 1101
- Philadelphia, PA 19107
- United States
Corporate Office
- 1315 Walnut Street
- Suite 1101
- Philadelphia, PA 19107
- United States
Strados Labs Timeline
Strados Labs Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 22. Secondary Transaction - Private | 01-Jan-2026 | Completed | Generating Revenue | |||
| 21. Later Stage VC (Series B) | 20-Dec-2025 | Completed | Generating Revenue | |||
| 20. Later Stage VC (Series A) | 27-Jan-2025 | Completed | Generating Revenue | |||
| 19. Later Stage VC | 17-Sep-2024 | Completed | Generating Revenue | |||
| 18. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 17. Accelerator/Incubator | 01-Jul-2023 | Completed | Generating Revenue | |||
| 16. Later Stage VC | 01-Jan-2023 | Completed | Generating Revenue | |||
| 15. Debt - General | 03-Oct-2022 | Completed | Generating Revenue | |||
| 14. Grant | 10-Mar-2022 | $990K | $7.19M | Completed | Generating Revenue | |
| 13. Later Stage VC (Series A) | 04-Nov-2021 | $4.5M | $7.19M | Completed | Generating Revenue |
Strados Labs Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 588,836 | $0.000010 | $5.36 | $5.36 | 1x | $5.36 | 9.82% | |
| Seed | 768,821 | $0.000010 | $3.8 | $3.8 | 1x | $3.8 | 12.73% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Strados Labs Comparisons
Industry
Financing
Details
Strados Labs Competitors (6)
One of Strados Labs’s 6 competitors is Health Care Originals, a Venture Capital-Backed company based in Rochester, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Health Care Originals | Venture Capital-Backed | Rochester, NY | ||||
| Samay | Venture Capital-Backed | Mountain View, CA | ||||
| M3DICINE | Venture Capital-Backed | Eight Mile Plains, Australia | ||||
| Respiri | Corporation | Melbourne, Australia | ||||
| 3M (Health Information Systems business) | Failed Transaction (M&A) | Saint Paul, MN |
Strados Labs Patents
Strados Labs Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022280631-A1 | Augmented artificial intelligence system and methods for physiological data processing | Inactive | 28-May-2021 | ||
| CA-3227002-A1 | Augmented artificial intelligence system and methods for physiological data processing | Pending | 28-May-2021 | ||
| EP-4348674-A1 | Augmented artificial intelligence system and methods for physiological data processing | Inactive | 28-May-2021 | ||
| US-20220378377-A1 | Augmented artificial intelligence system and methods for physiological data processing | Inactive | 28-May-2021 | ||
| WO-2022250779-A1 | Augmented artificial intelligence system and methods for physiological data processing | Inactive | 28-May-2021 | A61B5/7203 |
Strados Labs Signals
Strados Labs Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Band of Angels | Angel Group | Minority | ||
| Broad Street Angels | Angel Group | Minority | ||
| Gopher Angels | Angel Group | Minority | ||
| 2468 Ventures | Venture Capital | Minority | ||
| National Science Foundation Innovation Corps Program | Accelerator/Incubator |
Strados Labs Acquisitions (1)
Strados Labs’s most recent deal was a Merger/Acquisition with NuvoAir Medical (Clinical Trial Business). The deal was made on 01-Mar-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| NuvoAir Medical (Clinical Trial Business) | 01-Mar-2026 | Merger/Acquisition | Laboratory Services (Healthcare) |
Strados Labs FAQs
-
When was Strados Labs founded?
Strados Labs was founded in 2016.
-
Where is Strados Labs headquartered?
Strados Labs is headquartered in Philadelphia, PA.
-
What is the size of Strados Labs?
Strados Labs has 48 total employees.
-
What industry is Strados Labs in?
Strados Labs’s primary industry is Monitoring Equipment.
-
Is Strados Labs a private or public company?
Strados Labs is a Private company.
-
What is Strados Labs’s current revenue?
The current revenue for Strados Labs is .
-
How much funding has Strados Labs raised over time?
Strados Labs has raised $20.5M.
-
Who are Strados Labs’s investors?
Band of Angels, Broad Street Angels, Gopher Angels, 2468 Ventures, and National Science Foundation Innovation Corps Program are 5 of 26 investors who have invested in Strados Labs.
-
Who are Strados Labs’s competitors?
Health Care Originals, Samay, M3DICINE, Respiri, and 3M (Health Information Systems business) are some of the 6 competitors of Strados Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process